美国 · 平台与数据 · MarketBeat
Merck Highlights Phase III Cancer Wins, Eyes 2027 Oncology Pipeline Catalysts
Merck & Co., Inc. (NYSE:MRK) outlined new oncology data and development plans at the European Society for Medical Oncology annual meeting, highlighting phase III results for its…
在 MarketBeat 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)



